SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001683168-24-002244
Filing Date
2024-04-10
Accepted
2024-04-09 19:40:26
Documents
3
Period of Report
2024-04-30

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT cns_def14a.htm DEF 14A 504660
2 GRAPHIC image_001.jpg GRAPHIC 160312
3 GRAPHIC image_002.jpg GRAPHIC 202939
  Complete submission text file 0001683168-24-002244.txt   1006299
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

IRS No.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39126 | Film No.: 24833937
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)